New universal breast cancer marker predicts recurrence and clinical outcome

Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Centre at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival...

Read the whole article on

More from